Dover Corp vs Novartis AG — how do they compare? Dover Corp trades at $208.79 (market cap $28.07B), while Novartis AG trades at $152.33 (market cap $295.37B). The key difference: Novartis AG is far larger — about 10.5× Dover Corp's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| DOV | NVS | |
|---|---|---|
Market Cap | $28.07B | $295.37B |
Sector | Industrials | Health |
52-Week High | $233.31 | $168.62 |
52-Week Low | $161.16 | $119.31 |
Enterprise Value | $29.58B | $336.69B |
Dividend Yield | 1.01% | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →